Gene editing Archives

Interview 3 Mar 2021

The Promises of CRISPR Genome Editing in Biomedicine

Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the advantages of CRISPR gene editing over other technologies and what the future holds for the…

March 3, 2021 - 5 minutesmins - By Larissa Warneck-Silvestrin

In Depth 1 Mar 2021

How Are European Biotechs Tackling the Cardiovascular Disease Problem?

Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality globally, making up over 30% of all deaths worldwide. While there are many established treatments…

March 1, 2021 - 9 minutesmins - By Farhan Mitha

In Depth 3 Feb 2021

Detecting Gene-Edited Food: The EU’s Nightmare

The EU imposed stringent controls on the commercialization of gene-edited food back in 2018. Years later, regulators are still working in the dark, with no established tests in place. The…

February 3, 2021 - 10 minutesmins - By Jonathan Smith

Interview 1 Feb 2021

Democratized DNA Synthesis: A Game-Changer Against Covid-19

DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions during lockdowns. Thomas Ybert, CEO of DNA Script, discusses the French company’s plans to protect…

February 1, 2021 - 6 minutesmins - By Jonathan Smith

DSCF0163 Pano small 1 scaled e1610442418197

Ethics, Investment, and What Comes Next in Gene-Editing Technologies

As next-generation gene-editing technologies become increasingly popular, biotech industry stakeholders carry the responsibility to ensure the ethical deployment of these tools through mindful partnerships and investments. Some call it the Bio…

January 11, 2021 - 5 minutesmins - By Maya Chergova

Best in Biotech 11 Jan 2021

The 21 European Biotech Companies To Watch in 2021

As we enter 2021, the biotech industry is already bustling with activity. Here’s a list of 21 European biotech companies likely to make a big splash in the biotechnology sector…

January 11, 2021 - 11 minutesmins - By Larissa Warneck-Silvestrin

What Factors can Ease the Complexity of Viral Vector Production for Gene Therapies?

While the global gene therapy market grows steadily, companies continue to face bottlenecks in the production of gene therapy’s essential building blocks: viral vectors and plasmids. Here, we compare the…

September 28, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin

In Depth 17 Aug 2020

Overcoming the Limitations of CRISPR Gene Editing with RNA Editing

A once forgotten technology, RNA editing has been gaining traction as a treatment for genetic conditions given its key advantages over CRISPR gene editing. Since CRISPR-Cas9 gene editing was first…

August 17, 2020 - 6 minutesmins - By External Contributor

News and Trends 29 Jul 2020

Update: DNA Script Raises €80M to Bring Rapid DNA Synthesis to the Lab

Update on 29/07/2020: DNA Script has increased the total raised in its Series B round to €80M ($89M). The additional funds will support the commercial launch of the company's benchtop…

July 29, 2020 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 Mar 2020

Evonetix Raises €27M Series B to Progress DNA Synthesis Technology

UK synthetic biology company Evonetix raised €27M in Series B funding to develop its fast DNA synthesis technology and produce a working prototype of the company’s desktop platform. New investor…

March 2, 2020 - 2 minutesmins - By Helen Albert

News and Trends 24 Jan 2020

Broad Institute Loses Appeal on European CRISPR Patent

A decision from the Boards of Appeal at the European Patent Office has revoked the claim of the Broad Institute to general patents on CRISPR/Cas9 gene editing technology, strengthening the…

January 24, 2020 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Jan 2020

DNA Data Storage Project Receives €20.7M from US Intelligence Agency

A DNA data storage project, involving French biotech DNA Script, has been awarded a contract worth up to €20.7M from the US Intelligence Advanced Research Projects Activity agency to develop…

January 18, 2020 - 3 minutesmins - By External Contributor

News and Trends 14 Jan 2020

Update: Horizon Discovery to Offer Partners Precise CRISPR Gene Editing

Update (14/01/20): Horizon Discovery will offer partners access to a precise version of CRISPR gene editing technology it has licensed from researchers at Rutgers University in the US. After a…

January 14, 2020 - 3 minutesmins - By Jonathan Smith

Taking CRISPR Safety to the Next Level

Gene therapies are experiencing a new era. CRISPR is current. CRISPR is trendy. CRISPR is on many researchers' minds. But its sudden success has also triggered concerns about its safety.…

December 11, 2019 - 7 minutesmins - By Larissa Warneck-Silvestrin

More News! 9 Oct 2019

Novo Nordisk and Bluebird Bio to Treat Hemophilia with Gene Editing

The Danish big pharma Novo Nordisk has joined forces with the US gene therapy company bluebird bio to develop next-generation gene editing treatments for hemophilia. The collaboration will last for…

October 9, 2019 - 1 minutemin - By Jonathan Smith

In Depth 11 Feb 2019

CRISPR: One Patent to Rule Them All

The gene editing tool CRISPR-Cas9 has revolutionized research in biology. With several parties fighting for the rights to the technology’s intellectual property, how difficult is it for third parties to…

February 11, 2019 - 5 minutesmins - By Timothé Cynober

Best in Biotech 28 Jan 2019

5 Real-Life Technologies Where Biotech Meets Science Fiction

From genetic engineering to synthetic food and immortality, biotech is getting surprisingly close to recreating science fiction in real life. Science fiction is always a step ahead of real-life…

January 28, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Aug 2018

UK Biotech Raises €73M to Target DNA Repair in Treating Cancer

Artios Pharma completed a €73M (£65M) Series B financing round to develop cancer treatments that target DNA repair mechanisms. Cancer occurs when cells in part of the body start dividing…

August 10, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 16 Jul 2018

CRISPR-Cas9 Shown to Cause Previously Unseen DNA Damage

Researchers at the Wellcome Trust Sanger Institute in the UK have found that gene editing with CRISPR-Cas9 can cause significantly more off-target damage to the DNA than previously thought. …

July 16, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

Interview 28 Jun 2018

The Race to Get CRISPR to the Clinic: Hope Versus Hype

In 2016, German pharma giant Bayer took a bold step and decided to partner with CRISPR Therapeutics to form a company that could join the race to be first into…

June 28, 2018 - 7 minutesmins - By Helen Albert

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Register for the Webinar

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering